SCHEMBL25845407

SCHEMBL25845407

Nc1ccc(N2CCC(C3CCCCC3)CC2)c(Cl)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.70
POLB P06746 3/20 0.70
HTT P42858 3/20 0.67
MAPT P10636 7/20 0.57
GAA P10253 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
KDM4E B2RXH2 3/20 0.55
RAD52 P43351 1/20 0.55
TDP1 Q9NUW8 2/20 0.47
MEN1 O00255 2/20 0.42
THRB P10828 2/20 0.42
KMT2A Q03164 2/20 0.42
NR4A1 P22736 1/20 0.42
PTK2B Q14289 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 1/20 0.41
HPGD P15428 2/20 0.41
TSHR P16473 2/20 0.41
GPR55 Q9Y2T6 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17264124 0.93 ALDH1A1 (0.75) ALDH1A1POLBHTTMAPTGAA
SCHEMBL160768 0.83 ALDH1A1 (1.00) ALDH1A1POLBHTTMAPTGAA
SCHEMBL30336487 0.83 ALDH1A1 (1.00) ALDH1A1POLBHTTMAPTGAA
SCHEMBL25845549 0.83 ALDH1A1 (0.55) ALDH1A1POLBHTTMAPTGAA
SCHEMBL12074538 0.81 ALDH1A1 (0.73) ALDH1A1POLBHTTMAPTGAA
SCHEMBL76629 0.81 ALDH1A1 (0.96) ALDH1A1POLBHTTMAPTGAA
SCHEMBL15358686 0.80 ALDH1A1 (0.81) ALDH1A1POLBHTTMAPTGAA
SCHEMBL29990026 0.80 ALDH1A1 (1.00) ALDH1A1POLBHTTMAPTGAA
SCHEMBL17450415 0.79 ALDH1A1 (0.68) ALDH1A1POLBHTTMAPTGAA
SCHEMBL6819782 0.78 ALDH1A1 (0.53) ALDH1A1POLBHTTMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691972-B2 Compounds for targeted degradation of BRD9 C4 THERAPEUTICS, INC. (US) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691972-B2 Compounds for targeted degradation of BRD9 BRD9, BRD1, BRWD1 ALDH1A1 4230/4885POLB 2403/4885HTT 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.